SrasV1, Hal, Checkpoint, bibRecord, 000094

Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir

Identifieur interne : 000094 ( Hal/Checkpoint ); précédent : 000093; suivant : 000095

Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir

Auteurs : J. Carbajo-Lozoya ; Y. Ma-Lauer ; M. Malesevic ; M. Theuerkorn ; V. Kahlert ; E. Prell ; B. Von Brunn ; D. Muth ; Thomas Baumert [France] ; C. Drosten ; G. Fischer ; A. Von Brunn

Source :

Virus Research [ 0168-1702 ] ; 2014.

RBID : Hal:hal-02494656

Abstract

Until recently, there were no effective drugs available blocking coronavirus (CoV) infection in humans and animals. We have shown before that CsA and FK506 inhibit coronavirus replication (Carbajo-Lozoya, J., Muller, M.A., Kallies, S., Thiel, V., Drosten, C., von Brunn, A. Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. Virus Res. 2012; Pfefferle, S., Schopf, J., Kogl, M., Friedel, C., Muller, M.A., Stellberger, T., von Dall'Armi, E., Herzog, P., Kallies, S., Niemeyer, D., Ditt, V., Kuri, T., Zust, R., Schwarz, F., Zimmer, R., Steffen, I., Weber, F., Thiel, V., Herrler, G., Thiel, H.-J., Schwegmann-Wessels, C., Pohlmann, S., Haas, J., Drosten, C. and von Brunn, A. The SARS-Coronavirus-host interactome: identification of cyclophilins as target for pan-Coronavirus inhibitors. PLoS Pathog., 2011). Here we demonstrate that CsD Alisporivir, NIM811 as well as novel non-immunosuppressive derivatives of CsA and FK506 strongly inhibit the growth of human coronavirus HCoV-NL63 at low micromolar, non-cytotoxic concentrations in cell culture. We show by qPCR analysis that virus replication is diminished up to four orders of magnitude to background levels. Knockdown of the cellular Cyclophilin A (CypA/PPIA) gene in Caco-2 cells prevents replication of HCoV-NL63, suggesting that CypA is required for virus replication. Collectively, our results uncover Cyclophilin A as a host target for CoV infection and provide new strategies for urgently needed therapeutic approaches.

Url:

https://hal.archives-ouvertes.fr/hal-02494656

DOI: 10.1016/j.virusres.2014.02.010

Links toward previous steps (curation, corpus...)

to stream Hal, to step Corpus: 000078
to stream Hal, to step Curation: 000078

Links to Exploration step

Hal:hal-02494656

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir</title>
<author><name sortKey="Carbajo Lozoya, J" sort="Carbajo Lozoya, J" uniqKey="Carbajo Lozoya J" first="J" last="Carbajo-Lozoya">J. Carbajo-Lozoya</name>
</author>
<author><name sortKey="Ma Lauer, Y" sort="Ma Lauer, Y" uniqKey="Ma Lauer Y" first="Y" last="Ma-Lauer">Y. Ma-Lauer</name>
</author>
<author><name sortKey="Malesevic, M" sort="Malesevic, M" uniqKey="Malesevic M" first="M" last="Malesevic">M. Malesevic</name>
</author>
<author><name sortKey="Theuerkorn, M" sort="Theuerkorn, M" uniqKey="Theuerkorn M" first="M" last="Theuerkorn">M. Theuerkorn</name>
</author>
<author><name sortKey="Kahlert, V" sort="Kahlert, V" uniqKey="Kahlert V" first="V" last="Kahlert">V. Kahlert</name>
</author>
<author><name sortKey="Prell, E" sort="Prell, E" uniqKey="Prell E" first="E" last="Prell">E. Prell</name>
</author>
<author><name sortKey="Von Brunn, B" sort="Von Brunn, B" uniqKey="Von Brunn B" first="B" last="Von Brunn">B. Von Brunn</name>
</author>
<author><name sortKey="Muth, D" sort="Muth, D" uniqKey="Muth D" first="D" last="Muth">D. Muth</name>
</author>
<author><name sortKey="Baumert, Thomas" sort="Baumert, Thomas" uniqKey="Baumert T" first="Thomas" last="Baumert">Thomas Baumert</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-447080" status="VALID">          <idno type="IdRef">226490971</idno>
          <idno type="RNSR">200615803F</idno>
          <orgName>Institut de Recherche sur les Maladies Virales et Hépatiques</orgName>
          <orgName type="acronym">IVH</orgName>
          <desc>            <address>              <addrLine>Institut de virologie, 3 rue Koeberlé, 67000 Strasbourg</addrLine>
              <country key="FR"></country>
            </address>
            <ref type="url">http://www.u1110.inserm.fr</ref>
          </desc>
          <listRelation>            <relation name="UMRS1110" active="#struct-199013" type="direct"></relation>
            <relation name="U1110" active="#struct-303623" type="direct"></relation>
          </listRelation>
        <tutelles><tutelle name="UMRS1110" active="#struct-199013" type="direct"><org type="institution" xml:id="struct-199013" status="VALID">          <orgName>Université de Strasbourg</orgName>
          <orgName type="acronym">UNISTRA</orgName>
          <desc>            <address>              <addrLine>4 rue Blaise Pascal - CS 90032 - 67081 Strasbourg cedex</addrLine>
              <country key="FR"></country>
            </address>
            <ref type="url">http://www.unistra.fr/</ref>
          </desc>
        </org>
</tutelle>
<tutelle name="U1110" active="#struct-303623" type="direct"><org type="institution" xml:id="struct-303623" status="VALID">          <idno type="IdRef">026388278</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>            <address>              <addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
              <country key="FR"></country>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName><settlement type="city">Strasbourg</settlement>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
</placeName>
<orgName type="university">Université de Strasbourg</orgName>
</affiliation>
</author>
<author><name sortKey="Drosten, C" sort="Drosten, C" uniqKey="Drosten C" first="C" last="Drosten">C. Drosten</name>
</author>
<author><name sortKey="Fischer, G" sort="Fischer, G" uniqKey="Fischer G" first="G" last="Fischer">G. Fischer</name>
</author>
<author><name sortKey="Von Brunn, A" sort="Von Brunn, A" uniqKey="Von Brunn A" first="A" last="Von Brunn">A. Von Brunn</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-02494656</idno>
<idno type="halId">hal-02494656</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-02494656</idno>
<idno type="url">https://hal.archives-ouvertes.fr/hal-02494656</idno>
<idno type="doi">10.1016/j.virusres.2014.02.010</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Hal/Corpus">000078</idno>
<idno type="wicri:Area/Hal/Curation">000078</idno>
<idno type="wicri:Area/Hal/Checkpoint">000094</idno>
<idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000094</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir</title>
<author><name sortKey="Carbajo Lozoya, J" sort="Carbajo Lozoya, J" uniqKey="Carbajo Lozoya J" first="J" last="Carbajo-Lozoya">J. Carbajo-Lozoya</name>
</author>
<author><name sortKey="Ma Lauer, Y" sort="Ma Lauer, Y" uniqKey="Ma Lauer Y" first="Y" last="Ma-Lauer">Y. Ma-Lauer</name>
</author>
<author><name sortKey="Malesevic, M" sort="Malesevic, M" uniqKey="Malesevic M" first="M" last="Malesevic">M. Malesevic</name>
</author>
<author><name sortKey="Theuerkorn, M" sort="Theuerkorn, M" uniqKey="Theuerkorn M" first="M" last="Theuerkorn">M. Theuerkorn</name>
</author>
<author><name sortKey="Kahlert, V" sort="Kahlert, V" uniqKey="Kahlert V" first="V" last="Kahlert">V. Kahlert</name>
</author>
<author><name sortKey="Prell, E" sort="Prell, E" uniqKey="Prell E" first="E" last="Prell">E. Prell</name>
</author>
<author><name sortKey="Von Brunn, B" sort="Von Brunn, B" uniqKey="Von Brunn B" first="B" last="Von Brunn">B. Von Brunn</name>
</author>
<author><name sortKey="Muth, D" sort="Muth, D" uniqKey="Muth D" first="D" last="Muth">D. Muth</name>
</author>
<author><name sortKey="Baumert, Thomas" sort="Baumert, Thomas" uniqKey="Baumert T" first="Thomas" last="Baumert">Thomas Baumert</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-447080" status="VALID">          <idno type="IdRef">226490971</idno>
          <idno type="RNSR">200615803F</idno>
          <orgName>Institut de Recherche sur les Maladies Virales et Hépatiques</orgName>
          <orgName type="acronym">IVH</orgName>
          <desc>            <address>              <addrLine>Institut de virologie, 3 rue Koeberlé, 67000 Strasbourg</addrLine>
              <country key="FR"></country>
            </address>
            <ref type="url">http://www.u1110.inserm.fr</ref>
          </desc>
          <listRelation>            <relation name="UMRS1110" active="#struct-199013" type="direct"></relation>
            <relation name="U1110" active="#struct-303623" type="direct"></relation>
          </listRelation>
        <tutelles><tutelle name="UMRS1110" active="#struct-199013" type="direct"><org type="institution" xml:id="struct-199013" status="VALID">          <orgName>Université de Strasbourg</orgName>
          <orgName type="acronym">UNISTRA</orgName>
          <desc>            <address>              <addrLine>4 rue Blaise Pascal - CS 90032 - 67081 Strasbourg cedex</addrLine>
              <country key="FR"></country>
            </address>
            <ref type="url">http://www.unistra.fr/</ref>
          </desc>
        </org>
</tutelle>
<tutelle name="U1110" active="#struct-303623" type="direct"><org type="institution" xml:id="struct-303623" status="VALID">          <idno type="IdRef">026388278</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>            <address>              <addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
              <country key="FR"></country>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName><settlement type="city">Strasbourg</settlement>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Alsace (région administrative)</region>
</placeName>
<orgName type="university">Université de Strasbourg</orgName>
</affiliation>
</author>
<author><name sortKey="Drosten, C" sort="Drosten, C" uniqKey="Drosten C" first="C" last="Drosten">C. Drosten</name>
</author>
<author><name sortKey="Fischer, G" sort="Fischer, G" uniqKey="Fischer G" first="G" last="Fischer">G. Fischer</name>
</author>
<author><name sortKey="Von Brunn, A" sort="Von Brunn, A" uniqKey="Von Brunn A" first="A" last="Von Brunn">A. Von Brunn</name>
</author>
</analytic>
<idno type="DOI">10.1016/j.virusres.2014.02.010</idno>
<series><title level="j">Virus Research</title>
<idno type="ISSN">0168-1702</idno>
<imprint><date type="datePub">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">              <p>Until recently, there were no effective drugs available blocking coronavirus (CoV) infection in humans and animals. We have shown before that CsA and FK506 inhibit coronavirus replication (Carbajo-Lozoya, J., Muller, M.A., Kallies, S., Thiel, V., Drosten, C., von Brunn, A. Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. Virus Res. 2012; Pfefferle, S., Schopf, J., Kogl, M., Friedel, C., Muller, M.A., Stellberger, T., von Dall'Armi, E., Herzog, P., Kallies, S., Niemeyer, D., Ditt, V., Kuri, T., Zust, R., Schwarz, F., Zimmer, R., Steffen, I., Weber, F., Thiel, V., Herrler, G., Thiel, H.-J., Schwegmann-Wessels, C., Pohlmann, S., Haas, J., Drosten, C. and von Brunn, A. The SARS-Coronavirus-host interactome: identification of cyclophilins as target for pan-Coronavirus inhibitors. PLoS Pathog., 2011). Here we demonstrate that CsD Alisporivir, NIM811 as well as novel non-immunosuppressive derivatives of CsA and FK506 strongly inhibit the growth of human coronavirus HCoV-NL63 at low micromolar, non-cytotoxic concentrations in cell culture. We show by qPCR analysis that virus replication is diminished up to four orders of magnitude to background levels. Knockdown of the cellular Cyclophilin A (CypA/PPIA) gene in Caco-2 cells prevents replication of HCoV-NL63, suggesting that CypA is required for virus replication. Collectively, our results uncover Cyclophilin A as a host target for CoV infection and provide new strategies for urgently needed therapeutic approaches.</p>
            </div>
</front>
</TEI>
<hal api="V3">          <titleStmt>            <title xml:lang="en">Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir</title>
            <author role="aut">              <persName>                <forename type="first">J</forename>
                <surname>Carbajo-Lozoya</surname>
              </persName>
              <idno type="halauthorid">11766365</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Y</forename>
                <surname>Ma-Lauer</surname>
              </persName>
              <idno type="halauthorid">11766366</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">M</forename>
                <surname>Malesevic</surname>
              </persName>
              <idno type="halauthorid">11766367</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">M</forename>
                <surname>Theuerkorn</surname>
              </persName>
              <idno type="halauthorid">11766368</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">V</forename>
                <surname>Kahlert</surname>
              </persName>
              <idno type="halauthorid">11766369</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">E</forename>
                <surname>Prell</surname>
              </persName>
              <idno type="halauthorid">11766370</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">B</forename>
                <surname>von Brunn</surname>
              </persName>
              <idno type="halauthorid">11766371</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">D</forename>
                <surname>Muth</surname>
              </persName>
              <idno type="halauthorid">11766372</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Thomas</forename>
                <surname>Baumert</surname>
              </persName>
              <email type="md5">bc91cc2712c3015ec2cc4fb979ae830a</email>
              <email type="domain">unistra.fr</email>
              <idno type="halauthorid">1436813</idno>
              <affiliation ref="#struct-447080"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">C</forename>
                <surname>Drosten</surname>
              </persName>
              <idno type="halauthorid">11766373</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">G</forename>
                <surname>Fischer</surname>
              </persName>
              <idno type="halauthorid">1205547</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">A</forename>
                <surname>von Brunn</surname>
              </persName>
              <idno type="halauthorid">11766374</idno>
            </author>
            <editor role="depositor">              <persName>                <forename>adeline</forename>
                <surname>rege</surname>
              </persName>
              <email type="md5">d35266c520c0e6b54ee7a42aa2ce7360</email>
              <email type="domain">unistra.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>            <edition n="v1" type="current">              <date type="whenSubmitted">2020-02-28 23:07:35</date>
              <date type="whenWritten">2014</date>
              <date type="whenModified">2020-02-29 01:35:16</date>
              <date type="whenReleased">2020-02-28 23:07:35</date>
              <date type="whenProduced">2014</date>
              <ref type="externalLink" target="https://doi.org/10.1016/j.virusres.2014.02.010"></ref>
            </edition>
            <respStmt>              <resp>contributor</resp>
              <name key="549677">                <persName>                  <forename>adeline</forename>
                  <surname>rege</surname>
                </persName>
                <email type="md5">d35266c520c0e6b54ee7a42aa2ce7360</email>
                <email type="domain">unistra.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>            <distributor>CCSD</distributor>
            <idno type="halId">hal-02494656</idno>
            <idno type="halUri">https://hal.archives-ouvertes.fr/hal-02494656</idno>
            <idno type="halBibtex">carbajolozoya:hal-02494656</idno>
            <idno type="halRefHtml">Virus Research, Elsevier, 2014, 184, pp.44-53. ⟨10.1016/j.virusres.2014.02.010⟩</idno>
            <idno type="halRef">Virus Research, Elsevier, 2014, 184, pp.44-53. ⟨10.1016/j.virusres.2014.02.010⟩</idno>
          </publicationStmt>
          <seriesStmt>            <idno type="stamp" n="UNIV-STRASBG">Université de Strasbourg</idno>
            <idno type="stamp" n="SITE-ALSACE">Archive ouverte du site Alsace</idno>
            <idno type="stamp" n="U1110">Institut de recherche sur les maladies virales et hépatiques</idno>
          </seriesStmt>
          <notesStmt>            <note type="audience" n="1">Not set</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>            <biblStruct>              <analytic>                <title xml:lang="en">Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir</title>
                <author role="aut">                  <persName>                    <forename type="first">J</forename>
                    <surname>Carbajo-Lozoya</surname>
                  </persName>
                  <idno type="halauthorid">11766365</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Y</forename>
                    <surname>Ma-Lauer</surname>
                  </persName>
                  <idno type="halauthorid">11766366</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">M</forename>
                    <surname>Malesevic</surname>
                  </persName>
                  <idno type="halauthorid">11766367</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">M</forename>
                    <surname>Theuerkorn</surname>
                  </persName>
                  <idno type="halauthorid">11766368</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">V</forename>
                    <surname>Kahlert</surname>
                  </persName>
                  <idno type="halauthorid">11766369</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">E</forename>
                    <surname>Prell</surname>
                  </persName>
                  <idno type="halauthorid">11766370</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">B</forename>
                    <surname>von Brunn</surname>
                  </persName>
                  <idno type="halauthorid">11766371</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">D</forename>
                    <surname>Muth</surname>
                  </persName>
                  <idno type="halauthorid">11766372</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Thomas</forename>
                    <surname>Baumert</surname>
                  </persName>
                  <email type="md5">bc91cc2712c3015ec2cc4fb979ae830a</email>
                  <email type="domain">unistra.fr</email>
                  <idno type="halauthorid">1436813</idno>
                  <affiliation ref="#struct-447080"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">C</forename>
                    <surname>Drosten</surname>
                  </persName>
                  <idno type="halauthorid">11766373</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">G</forename>
                    <surname>Fischer</surname>
                  </persName>
                  <idno type="halauthorid">1205547</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">A</forename>
                    <surname>von Brunn</surname>
                  </persName>
                  <idno type="halauthorid">11766374</idno>
                </author>
              </analytic>
              <monogr>                <idno type="halJournalId" status="VALID">19855</idno>
                <idno type="issn">0168-1702</idno>
                <title level="j">Virus Research</title>
                <imprint>                  <publisher>Elsevier</publisher>
                  <biblScope unit="volume">184</biblScope>
                  <biblScope unit="pp">44-53</biblScope>
                  <date type="datePub">2014</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1016/j.virusres.2014.02.010</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>            <langUsage>              <language ident="en">English</language>
            </langUsage>
            <textClass>              <classCode scheme="halDomain" n="sdv.mhep">Life Sciences [q-bio]/Human health and pathology</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">              <p>Until recently, there were no effective drugs available blocking coronavirus (CoV) infection in humans and animals. We have shown before that CsA and FK506 inhibit coronavirus replication (Carbajo-Lozoya, J., Muller, M.A., Kallies, S., Thiel, V., Drosten, C., von Brunn, A. Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. Virus Res. 2012; Pfefferle, S., Schopf, J., Kogl, M., Friedel, C., Muller, M.A., Stellberger, T., von Dall'Armi, E., Herzog, P., Kallies, S., Niemeyer, D., Ditt, V., Kuri, T., Zust, R., Schwarz, F., Zimmer, R., Steffen, I., Weber, F., Thiel, V., Herrler, G., Thiel, H.-J., Schwegmann-Wessels, C., Pohlmann, S., Haas, J., Drosten, C. and von Brunn, A. The SARS-Coronavirus-host interactome: identification of cyclophilins as target for pan-Coronavirus inhibitors. PLoS Pathog., 2011). Here we demonstrate that CsD Alisporivir, NIM811 as well as novel non-immunosuppressive derivatives of CsA and FK506 strongly inhibit the growth of human coronavirus HCoV-NL63 at low micromolar, non-cytotoxic concentrations in cell culture. We show by qPCR analysis that virus replication is diminished up to four orders of magnitude to background levels. Knockdown of the cellular Cyclophilin A (CypA/PPIA) gene in Caco-2 cells prevents replication of HCoV-NL63, suggesting that CypA is required for virus replication. Collectively, our results uncover Cyclophilin A as a host target for CoV infection and provide new strategies for urgently needed therapeutic approaches.</p>
            </abstract>
          </profileDesc>
        </hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Hal/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000094 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Hal/Checkpoint/biblio.hfd -nk 000094 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Hal
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Hal:hal-02494656
   |texte=   Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir

Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri